Morgan Stanley lowered the firm’s price target on Healthpeak Properties (DOC) to $21 from $22 and keeps an Overweight rating on the shares after updating the firm’s estimates to reflect Q2 earnings.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOC:
- Deutsche downgrades Healthpeak to Hold on biotech challenges
- Healthpeak Properties downgraded to Hold from Buy at Deutsche Bank
- Ex-Dividend Date Nearing for These 10 Stocks – Week of August 18, 2025
- Healthpeak Properties Completes $500 Million Senior Notes Offering
- Healthpeak Properties Announces $500M Senior Notes Offering